-
Consumer focus on value, legislative push lead to record-breaking growth in 2016
The graying of the baby boomers, an increased focus on supplementing healthier lifestyles and the steady stream of nasal corticosteroid brands making their way from prescription-only to the more value-oriented OTC aisle were just three significant drivers behind the growth of over-the-counter medicines in 2016.
(To view the full Category Review, click here.)
-
House reintroduces DXM Abuse Prevention Act
WASHINGTON — Reps. Bill Johnson, R-Ohio, and Doris Matsui, D-Calif., both members of the House Energy and Commerce Committee, introduced the DXM Abuse Prevention Act on Thursday in a bipartisan effort to prevent teen abuse of over-the-counter cough medicines containing the cough suppressant dextromethorphan, commonly referred to the DXM.
The bill would establish a national age-18 requirement for the purchase of the medicines containing DXM. Over the past several years,12 states have addressed this issue by passing similar legislation.